KALA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
KALA BIO Inc is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows weak financial performance, insider selling, and no positive catalysts or trading signals to support a buy decision.
The stock is showing bearish moving averages (SMA_200 > SMA_20 > SMA_5), indicating a downward trend. The RSI is neutral at 24.098, and the MACD is slightly positive but contracting, suggesting no strong momentum. The pre-market price is $0.1639, up 6.43%, but this is not supported by strong technical indicators.
NULL identified. No recent news or significant positive developments.
Insiders are selling, with a 177.30% increase in selling activity over the last month. Financial performance is weak, with negative YoY growth in net income (-108.39%) and EPS (-38.51%).
In Q4 2025, revenue remained at 0 with no growth. Net income dropped to -$686,000, down -108.39% YoY, and EPS fell to -1.07, down -38.51% YoY. Gross margin is 0, showing no profitability.
No analyst ratings or price target changes were provided.
